Title:
ヒト胎盤灌流液およびヒト胎盤由来中間ナチュラルキラー細胞を使用した腫瘍抑制
Document Type and Number:
Japanese Patent JP6616248
Kind Code:
B2
Abstract:
The invention provides placental perfusate cells, CD56, CD16placental intermediate natural killer cells, and combinations of natural killer cells isolated from placental perfusate and natural killer cells isolated from umbilical cord blood which is isolated from the placenta from which said placental perfusate is obtained. Further provided herein are such cells and cell combinations for use in a method of suppressing the proliferation of tumor cells, in particular for the treatment of an individual having a tumor. Also provided herein are composition comprising isolated CD56, CD16natural killer cells which are isolated from placental perfusate and wherein the natural killer cells comprise at least 50% of cells in the composition.
Inventors:
Jean, Jaoki
Voskinarian-Bath, Vanessa, A..
Can, phosphorus
Padreya, Neerabu Dillyp
Voskinarian-Bath, Vanessa, A..
Can, phosphorus
Padreya, Neerabu Dillyp
Application Number:
JP2016119378A
Publication Date:
December 04, 2019
Filing Date:
June 15, 2016
Export Citation:
Assignee:
Anthropogenesis Corporation
International Classes:
A61K35/50; A61K31/454; A61K35/17; A61P35/00; A61P35/02; C12N5/0783; A61K35/12
Domestic Patent References:
| JP6148262B2 |
Attorney, Agent or Firm:
Hiroshi Kobayashi
Mami Hino
Norio Omori
Tomohiro Maruyama
Yasuhito Suzuki
Mami Hino
Norio Omori
Tomohiro Maruyama
Yasuhito Suzuki